Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series

BACKGROUND: Clozapine has a unique efficacy profile among individuals suffering from treatment-resistant schizophrenia, but is associated with hematological side effects. The use of granulocyte colony-stimulating factors (G-CSF) to allow clozapine continuation or rechallenge has emerged as a promisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Béchard, Laurent, Corbeil, Olivier, Plante, Maude, Thivierge, Marc-André, Lafrenière, Charles-Émile, Roy, Marc-André, Demers, Marie-France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436292/
https://www.ncbi.nlm.nih.gov/pubmed/34229529
http://dx.doi.org/10.1177/02698811211029737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436292/
https://www.ncbi.nlm.nih.gov/pubmed/34229529
http://dx.doi.org/10.1177/02698811211029737

Ejemplares similares